More derm therapies approved in 2022

Canadian dermatologists assess benefits of new treatments

A new biologic for psoriasis and a new tyrosine kinase-2 inhibitor for psoriasis, the long-term safety of
an IL-17 to treat pediatric patients with psoriasis, the availability of a new laser to treat acne, more options for atopic dermatitis (AD) patients, and expanding the use of deroofing in the management of
HS, are all advances that are highly encouraging to Canadian dermatologists.

Click here to read the full article.

Thinking of visiting Toronto’s premier skin clinic soon?

Fill out the inquiry form below and let us know your area of interest.

  • Optional

Call us today @ 416.633.0001

    Shopping Bag
    Your cart is emptyReturn to Shop
      Calculate Shipping
      Apply Coupon